| Literature DB >> 24177676 |
Shang-Kwei Wang1, Mu-Keng Hsieh, Chang-Yih Duh.
Abstract
Continuing chemical investigation on the acetone extracts of the soft coral Sarcophyton ehrenbergi collected off the coast of San-hsian-tai, Taitong County, Taiwan led to the isolation of two new diterpenoids, ehrenbergol C and acetyl ehrenberoxide B (1 and 2). The structures of these isolated metabolites were elucidated through extensive spectroscopic analyses. Moreover, in vitro tests show that compounds 1 and 2 displayed antiviral activity towards human cytomegalovirus, with EC50 of 20 and 8.0 µg/mL, respectively.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24177676 PMCID: PMC3853730 DOI: 10.3390/md11114318
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Soft coral Sarcophyton ehrenbergi.
Figure 2Structures of compounds 1 and 2.
NMR data for compound 1.
| Position | HMBC | COSY | NOESY | ||
|---|---|---|---|---|---|
| 1 | 141.4, qC | ||||
| 2 | 205.9, qC | ||||
| 3 | 2.13, d (2.0) | 60.8, CH | 2, 4, 16 | 16, 18 | 5a |
| 4 | 83.2, qC | ||||
| 5a | 3.11, ddd (12.0, 8.8, 3.2) | 34.3, CH2 | 6b, 18 | 3 | |
| 5b | 1.67 m | 6 | 18 | ||
| 6a | 1.56, m | 28.5, CH2 | 7 | ||
| 6b | 1.84, m | 7 | 5a, 7 | 7 | |
| 7 | 3.82, dd (10.4, 6.0) | 85.6, CH | 8, 9 | 6a, 6b | 6b, 19 |
| 8 | 73.9, qC | ||||
| 9a | 1.59, m | 36.6, CH2 | 8, 10, 11 | ||
| 9b | 1.45, m | 8, 10, 11 | 10 | ||
| 10a | 1.98, m | 9b, 11 | 13b | ||
| 10b | 1.99, m | 23.8, CH2 | 9, 12 | 9b, 11 | 11, 19 |
| 11 | 6.76, t (7.2) | 144.7, CH | 9, 10, 20 | 10 | 10b |
| 12 | 130.7, qC | ||||
| 13a | 2.46, m | 24.3, CH2 | 11, 12, 14, 20 | 14 | |
| 13b | 2.63, m | 1, 11, 12, 14, 20 | 14 | 14a | |
| 14a | 2.46, m | 21.8, CH2 | 1, 2, 13, 15 | 13 | 13b |
| 14b | 2.47, m | 13 | 17 | ||
| 15 | 168.9, qC | ||||
| 16 | 4.92, d (6.0) | 75.4, CH | 1, 4, 15 | 3, 17 | 17, 18 |
| 17 | 1.94, s | 13.4, CH3 | 1, 15, 16 | 16 | 14b, 16 |
| 18 | 1.42, s | 28.4, CH3 | 3, 4, 5 | 5a | 7, 5b, 16 |
| 19 | 1.09, s | 24.2, CH3 | 7, 8, 9 | 6a, 7, 10b | |
| 20 | 168.2, qC | ||||
| OMe | 3.75, s | 51.6, CH3 | 20 |
a Spectra were measured in CDCl3 (400 MHz); b Spectra were measured in CDCl3 (100 MHz).
Figure 3COSY and HMBC correlations of compounds 1 and 2.
Figure 4NOESY correlations of compound 1.
NMR data for compound 2.
| Position | HMBC | COSY | NOESY | ||
|---|---|---|---|---|---|
| 1 | 151.0, qC | ||||
| 2 | 6.05, d (8.4) | 117.9, CH | 14, 15 | 3, 15, 16, 18 | |
| 3 | 6.37, d (8.4) | 123.5, CH | 5, 18 | 18 | 2, 7, 13a, 14a |
| 4 | 132.6, qC | ||||
| 5a | 2.10, m | 37.9, CH2 | 2 | 6a | 6b |
| 5b | 2.27, m | ||||
| 6a | 2.04, m | 30.8, CH2 | 5a, 7 | ||
| 6b | 1.84, m | 7 | 5a, 19 | ||
| 7 | 4.05, t (3.2) | 75.3, CH | 6a, 6b | 3, 9a, 13a | |
| 8 | 87.0, qC | ||||
| 9a | 2.13, m | 36.6, CH2 | 7, 11 | ||
| 9b | 2.09, m | 10a | |||
| 10a | 1.74 m | 29.2, CH2 | 9b | ||
| 10b | 1.08, m | 11 | 19, 20 | ||
| 11 | 3.16, dd (10.0, 2.8) | 78.3, CH | 10b | 9a, 10a, 13a | |
| 12 | 80.4, qC | ||||
| 13a | 1.97, m | 37.4, CH2 | 12 | 14a | 3, 7, 11 |
| 13b | 1.82, m | 14b | |||
| 14a | 2.64, m | 24.3, CH2 | 1 | 13a | 3 |
| 14b | 1.81, m | 1 | 13b | ||
| 15 | 2.32, m | 36.9, CH | 1, 16, 17 | 2, 16, 17 | |
| 16 | 1.06, d (6.8) | 21.5, CH3 | 1, 15, 17 | 15 | 2, 15 |
| 17 | 1.04, d (6.8) | 21.8, CH3 | 1, 15, 16 | 15 | 15 |
| 18 | 1.76, s | 17.9, CH3 | 3, 4, 5 | 3 | 2 |
| 19 | 1.48, s | 18.9, CH3 | 7, 8, 9 | 6b, 10b | |
| 20 | 1.11, s | 18.1, CH3 | 11, 12, 13 | 10b, 14b | |
| 21 | 169.8,qC | ||||
| OAc | 1.66, s | 22.1, CH3 | 21 |
a Spectra were measured in C6D6 (400 MHz); b Spectra were measured in C6D6 (100 MHz).
Figure 5NOESY correlations of compound 2.
Cytotoxicity and anti-HCMV activity of 1 and 2.
| Compounds | EC50 (µg/mL) | ||||
|---|---|---|---|---|---|
| A549 | HT-29 | P-388 | HEL | Anti-HCMV | |
| >50 | >50 | 25.9 | >50 | 20 | |
| >50 | >50 | 24.7 | >50 | 8.0 | |